https://pubmed.ncbi.nlm.nih.gov/32636123/

Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1564-1572.
doi: 10.1016/j.numecd.2020.05.012.Epub 2020 May 28.

PNPLA3 gene polymorphism is associated with liver steatosis in children with Down syndrome

Diletta Valentini 1, Antonella Mosca 2, Chiara Di Camillo 3, Annalisa Crudele 4, Maria Rita Sartorelli 2, Vittorio Scoppola 3, Luigi Tarani 5, Alberto Villani 3, Massimiliano Raponi 6, Antonio Novelli 7, Anna Alisi 8

Abstract

Background and aims: We previously demonstrated that children with Down syndrome (DS) exhibited a greater risk of steatosis than the general pediatric population. This trend was independent of obese phenotype, thus suggesting a role of genetic predisposition. Therefore, we investigated the prevalence of non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS) in function of genetic susceptibility and adipocytokine levels in children with DS.

Methods and results: A total of 84 Caucasian children with DS (age range 5-17 years), were included in this study. For all children, we collected data on anthropometric and biochemical parameters, and liver ultrasound (US). We also measured adipocytokines circulating levels and specific polymorphisms closed to NAFLD. We found a prevalence of 64.3% of liver steatosis at US, with a severe steatosis of about 4% in children with DS. The presence of steatosis in children with DS was associated with the presence of patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 variant, which also correlated with interleukin (IL)-6 levels. Moreover, we found that the 52.4% had a waist circumference > 90th percentile, 21.4% were hypertensive, 7.14% had hyperglycemia, 9.5% had hypertriglyceridemia, and 17.9% showed high-density lipoprotein cholesterol ≤ 40 mg/dl. Finally, the IL-6 and adiponectin levels correlated with steatosis, and several adipocytokines correlated with single MetS traits in children with DS.

Conclusion: The present study explores for the first time potential pathomechanisms connecting pediatric NAFLD and MetS in DS. We found that the PNPLA3 variant is associated with steatosis, but not with MetS, in children with DS.